SFM-Protein: Integrative Co-evolutionary Pre-training for Advanced Protein Sequence Representation

Proteins, essential to biological systems, perform functions intricately linked to their three-dimensional structures. Understanding the relationship between protein structures and their amino acid sequences remains a core challenge in protein modeling. While traditional protein foundation models benefit from pre-training on vast unlabeled datasets, they often struggle to capture critical co-evolutionary information, which evolutionary-based methods excel at. In this study, we introduce a novel pre-training strategy for protein foundation models that emphasizes the interactions among amino acid residues to enhance the extraction of both short-range and long-range co-evolutionary features from sequence data. Trained on a large-scale protein sequence dataset, our model demonstrates superior generalization ability, outperforming established baselines of similar size, including the ESM model, across diverse downstream tasks. Experimental results confirm the model's effectiveness in integrating co-evolutionary information, marking a significant step forward in protein sequence-based modeling.

Control Risk for Potential Misuse of Artificial Intelligence in Science

The expanding application of Artificial Intelligence (AI) in scientific fields presents unprecedented opportunities for discovery and innovation. However, this growth is not without risks. AI models in science, if misused, can amplify risks like creation of harmful substances, or circumvention of established regulations. In this study, we aim to raise awareness of the dangers of AI misuse in science, and call for responsible AI development and use in this domain. We first itemize the risks posed by AI in scientific contexts, then demonstrate the risks by highlighting real-world examples of misuse in chemical science. These instances underscore the need for effective risk management strategies. In response, we propose a system called SciGuard to control misuse risks for AI models in science. We also propose a red-teaming benchmark SciMT-Safety to assess the safety of different systems. Our proposed SciGuard shows the least harmful impact in the assessment without compromising performance in benign tests. Finally, we highlight the need for a multidisciplinary and collaborative effort to ensure the safe and ethical use of AI models in science. We hope that our study can spark productive discussions on using AI ethically in science among researchers, practitioners, policymakers, and the public, to maximize benefits and minimize the risks of misuse.

Towards Predicting Equilibrium Distributions for Molecular Systems with Deep Learning

Advances in deep learning have greatly improved structure prediction of molecules. However, many macroscopic observations that are important for real-world applications are not functions of a single molecular structure, but rather determined from the equilibrium distribution of structures. Traditional methods for obtaining these distributions, such as molecular dynamics simulation, are computationally expensive and often intractable. In this paper, we introduce a novel deep learning framework, called Distributional Graphormer (DiG), in an attempt to predict the equilibrium distribution of molecular systems. Inspired by the annealing process in thermodynamics, DiG employs deep neural networks to transform a simple distribution towards the equilibrium distribution, conditioned on a descriptor of a molecular system, such as a chemical graph or a protein sequence. This framework enables efficient generation of diverse conformations and provides estimations of state densities. We demonstrate the performance of DiG on several molecular tasks, including protein conformation sampling, ligand structure sampling, catalyst-adsorbate sampling, and property-guided structure generation. DiG presents a significant advancement in methodology for statistically understanding molecular systems, opening up new research opportunities in molecular science.

Predicting the protein-ligand affinity from molecular dynamics trajectories

The accurate protein-ligand binding affinity prediction is essential in drug design and many other molecular recognition problems. Despite many advances in affinity prediction based on machine learning techniques, they are still limited since the protein-ligand binding is determined by the dynamics of atoms and molecules. To this end, we curated an MD dataset containing 3,218 dynamic protein-ligand complexes and further developed Dynaformer, a graph-based deep learning framework. Dynaformer can fully capture the dynamic binding rules by considering various geometric characteristics of the interaction. Our method shows superior performance over the methods hitherto reported. Moreover, we performed virtual screening on heat shock protein 90 (HSP90) by integrating our model with structure-based docking. We benchmarked our performance against other baselines, demonstrating that our method can identify the molecule with the highest experimental potency. We anticipate that large-scale MD dataset and machine learning models will form a new synergy, providing a new route towards accelerated drug discovery and optimization.

Multi-view Graph Contrastive Representation Learning for Drug-Drug Interaction Prediction

Potential Drug-Drug Interaction(DDI) occurring while treating complex or co-existing diseases with drug combinations may cause changes in drugs' pharmacological activity. Therefore, DDI prediction has been an important task in the medical healthy machine learning community. Graph-based learning methods have recently aroused widespread interest and are proved to be a priority for this task. However, these methods are often limited to exploiting the inter-view drug molecular structure and ignoring the drug's intra-view interaction relationship, vital to capturing the complex DDI patterns. This study presents a new method, multi-view graph contrastive representation learning for drug-drug interaction prediction, MIRACLE for brevity, to capture inter-view molecule structure and intra-view interactions between molecules simultaneously. MIRACLE treats a DDI network as a multi-view graph where each node in the interaction graph itself is a drug molecular graph instance. We use GCN to encode DDI relationships and a bond-aware attentive message propagating method to capture drug molecular structure information in the MIRACLE learning stage. Also, we propose a novel unsupervised contrastive learning component to balance and integrate the multi-view information. Comprehensive experiments on multiple real datasets show that MIRACLE outperforms the state-of-the-art DDI prediction models consistently.